Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 28, 2012; 18(32): 4391-4398
Published online Aug 28, 2012. doi: 10.3748/wjg.v18.i32.4391
Published online Aug 28, 2012. doi: 10.3748/wjg.v18.i32.4391
Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients
Mariam Aguas, Guillermo Bastida, Belén Beltrán, Marisa Iborra, Pilar Nos, Gastroenterology Unit, Department of Digestive Disease, Networked Biomedical Research Center for Hepatic and Digestive Diseases, La Fe University and Politechnic Hospital, 46026 Valencia, Spain
Elena Cerrillo, Cristina Sánchez-Montes, Department of Gastroenterology, La Fe University and Politechnic Hospital, 46026 Valencia, Spain
Fernando Muñoz, Leon Hospital Complex, 42132 León, Spain
Jesús Barrio, Río Hortega University Hospital, 47001 Valladolid, Spain
Sabino Riestra, Central University Hospital of Asturias, 33006 Oviedo, Spain
Author contributions: Aguas M and Nos P designed and set up the study; Aguas M, Cerrillo E, Beltrán B, Iborra M, Sánchez-Montes C, Muñoz F, Barrio J and Riestra S contributed to data acquisition; Aguas M and Bastida G analyzed and interpreted data; and Aguas M, Bastida G and Nos P wrote the paper and approved the final version.
Correspondence to: Mariam Aguas, MD, Gastroenterology Unit, Department of Digestive Disease, Networked Biomedical Research Center for Hepatic and Digestive Diseases, La Fe University and Politechnic Hospital, Av. Bulevar s/n, 46026 Valencia, Spain. aguas_mar@gva.es
Telephone: +34-96-1246257 Fax: +34-96-1246257
Received: May 8, 2012
Revised: July 27, 2012
Accepted: August 3, 2012
Published online: August 28, 2012
Revised: July 27, 2012
Accepted: August 3, 2012
Published online: August 28, 2012
Core Tip